In prostate cancer, Myc indirectly affects the levels of these proteins and targets the mitochondrial chaperone protein tumor necrosis factor receptor‐associated protein 1, which mediates mitochondrial protein folding and functional levels of OXPHOS [176]. This evidence concerns the gene MYC and prostate carcinoma.